Rare diseases
Investigational molecules
Locations
Back to Poland33 clinical trials in Biala Podlaska, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
PolandStudy on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
PolandStudy on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation
PolandStudy on Ibrutinib and Venetoclax for Patients with Untreated Chronic Lymphocytic Leukemia
PolandStudy of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis
PolandStudy of RVU120 for Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
PolandStudy on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer
PolandStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
PolandPolandA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandStudy of Subcutaneous Nivolumab for Patients with Previously Treated Advanced or Metastatic Clear Cell Kidney Cancer
PolandStudy on Trastuzumab Deruxtecan and Drug Combination for Patients with High-Risk HER2-Positive Early Breast Cancer
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on heart failure prevention and treatment, including studies evaluating new combination therapies with drugs like baxdrostat and dapagliflozin. Research also encompasses atrial fibrillation management strategies.
Studies aim to reduce cardiovascular mortality and improve patient outcomes through targeted therapeutic approaches.
Comprehensive research in various cancer types, including colorectal cancer, breast cancer, and lung cancer. Trials evaluate novel treatment combinations and targeted therapies for both early-stage and metastatic disease.
Focus on developing personalized treatment approaches and improving survival outcomes across multiple cancer types.
Groundbreaking studies in blood disorders, particularly leukemia and multiple myeloma. Research includes novel combination therapies and treatment strategies for both newly diagnosed and relapsed/refractory cases.
Trials aim to improve treatment outcomes and develop more effective therapeutic options for patients with blood cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
